Promising Results for Tricuspid Repair

Courtesy of Dr. Carlos Fava.

Tricuspid regurgitation (TR) is more common than we thought. Around 1.6 million people in the US and over 3 million in Europe experience significant TR.

Reparación de la válvula tricúspide con la técnica del Mitra ClipIt usually has a functional cause and its negative impact on patient prognosis is strong.

 

Its surgical treatment is challenging, and it is important that its resolution not leave significant stenosis behind.

 

Outcomes of the TRI-REPAIR study including 30 patients receiving percutaneous treatment with Cardioband were analyzed.


Read also: Is Tricuspid Regurgitation after TAVR Significant?


The inclusion criteria were severe symptomatic functional TR, annulus size ≥40 mm, stable medical treatment, and ineligibility for surgery. Researchers excluded patients with ejection fraction <30%, recent acute myocardial infarction, unstable angina within 30 days, systolic pulmonary artery pressure >60 mmHg, prior tricuspid repair, other moderate to severe valve disease, pacemaker implantation, anemia, dialysis, life expectancy <12 months, or cardiac cachexia.

 

Patient age was 75.2 years old, most subjects were female, and most were classified as New York Heart Association functional class III/IV. The N-terminal pro–B-type natriuretic peptide was 2924.9 pg/mL. The ejection fraction was 58%; 28 patients experienced atrial fibrillation and 16 experienced moderate to severe renal impairment. The EuroSCORE II was 4.1% and the Society of Thoracic Surgeons (STS) mortality score was 2.1%.

 

There was technical success with all patients.


Read also: Tricuspid Regurgitation: MitraClip Improves Survival.


Three patients died during the 6-month follow-up period. Overall, 76% of the population experienced clinical improvement; 88% of patients were deemed NYHA functional class I-II, the six-minute walk distance improved by 60 m (266 to 326, p = 0.003), and quality of life (according to Kansas City Cardiomyopathy Questionnaire [KCCQ] score) improved by 24 points (p < 0.01). Doppler echocardiography showed reductions of annular diameter of 9% (42 mm vs. 38 mm; p < 0.01), effective regurgitant orifice area of 50% (0.8 cm2 vs. 0.4 cm2), and mean vena contracta width of 28% (1.2 cm vs. 0.9 cm; p < 0.01).

 

Conclusion

After a 6-month follow-up, the Cardioband system seems to be safe in patients with moderate to severe functional tricuspid regurgitation. There was a significant reduction of tricuspid regurgitation, a decrease of annular dimensions, and improvements in heart failure symptoms, quality of life, and exercise capacity. Further studies are required to validate these initial promising results.

 

Courtesy of Dr. Carlos Fava.

 

Original title: 6-Month Outcomes of Tricuspid Valve Reconstruction for Patients with Severe Tricuspid Regurgitation.

Reference: Georg Nickenig et al. J Am Coll Cardiol 2019;73:1905-15.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...